Bharat Biotech dispatches first shipment of iNCOVACC across India
DCGI's SEC to hold discussion on "five arms" booster dose
DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in...
Bharat Biotech applies for market authorisation from DCGI
iNCOVACC becomes first intranasal COVID vaccine to get EUA
New Delhi [India], September 6 (ANI): The Drugs Controller General of India (DCGI) rendered an emergency use...
India's first intranasal vaccine by Bharat Biotech gets DCGI nod
New Delhi [India], September 6 (ANI): The Bharat Biotech on Tuesday got emergency use authorisation from the...
Bharat Biotech completes clinical development for nasal vaccine
Bharat Biotech's intranasal booster vaccine can be a...
New Delhi [India], March 11 (ANI): Bharat Biotech's intranasal booster vaccine can be a game-changer if it...
Bharat Biotech gets DCGI's nod to conduct intranasal booster...
New Delhi [India], January 28 (ANI): The Drugs Controller General of India (DCGI) on Friday granted permission to...
Bharat Biotech gets SEC approval for phase 3 clinical trials...
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India...
AIIMS Delhi to conduct Phase 2/3 clinical trials of Bharat...
New Delhi [India], September 8 (ANI): The All India Institute Of Medical Sciences (AIIMS) here will be starting...
Bharat Biotech inks licensing deal with WUSM to advance...
Bharat Biotech developing 'CoroFlu' intranasal vaccine for...
Hyderabad (Telangana) [India], Apr 4 (ANI): Bharat biotech is developing a one drop COVID-19 intranasal vaccine...
Copyright © aninews.in | All Rights Reserved.